✦ LIBER ✦

Surrogate markers in clinical trials—Challenges and opportunities

✍ Scribed by Raphaël Duivenvoorden; Eric de Groot; Erik S.G. Stroes; John J.P. Kastelein

Book ID: 118422393
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 679 KB
Volume: 206
Category: Article
ISSN: 0021-9150
DOI: 10.1016/j.atherosclerosis.2008.12.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Surrogate markers in antiangiogenesis cl

Surrogate markers in antiangiogenesis clinical trials

✍ Davis, D W; McConkey, D J; Abbruzzese, J L; Herbst, R S 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 249 KB

SERMs, Ethnicity, and Clinical Trials :

SERMs, Ethnicity, and Clinical Trials : Opportunities and Challenges

✍ ANNE L. TAYLOR 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Pediatric Stroke: Opportunities and Chal

Pediatric Stroke: Opportunities and Challenges in Planning Clinical Trials

✍ Steven G. Pavlakis; Deborah G. Hirtz; Gabrielle deVeber 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 53 KB

The opportunities and challenges in cond

The opportunities and challenges in conducting clinical trials globally

✍ Bansal, Navneeta 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 598 KB

Surrogate endpoints in clinical trials

✍ Lawrence Friedman; Salim Yusuf 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Validation of Surrogate Markers in Multi

Validation of Surrogate Markers in Multiple Randomized Clinical Trials with Repeated Measurements

✍ Ariel Alonso; Helena Geys; Geert Molenberghs; Michael G. Kenward; Tony Vangeneug 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB 👁 2 views